Levothyroxine Sodium Tablet
Product Images NDC 0480-8701

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Levothyroxine Sodium (NDC 0480-8701). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Teva Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (Image 1)

FDA Label Image

Label 150 Mcg, 90 Tablets (Image 10)

This is a description of the medication Levothyroxine, 150 mcg (0.15 mg) produced by Teva Pharmaceuticals. It comes in a bottle with 90 sodium tablets, which should be kept out of reach of children. The tablets should be stored at 25°C (77°F) with excursions permitted to 15° to 30°C (59° 1o 86°F). The medication is manufactured in Croatia by Pliva Hvatska do and is only available with a prescription. The literature accompanying the medication provides complete prescribing information.*

FDA Label Image

Label 175 Mcg, 90 Tablets (Image 11)

The text appears to be a medication label with instructions for usage, storage and manufacturing details for tablets containing 175 mcg of levothyroxine sodium, USP. The medication should be stored in a tightly sealed, light-resistant container, away from children, at a temperature range of 15°-30°C (59°-86°F), and should be dispensed as per the recommended dosage guidelines provided in the accompanying literature. The tablets are manufactured in Croatia by Pliva Hivatska d.0. and distributed by Teva Pharmaceuticals in Parsippany, N.J.*

FDA Label Image

Label 200 Mcg, 90 Tablets (Image 12)

Levothyroxine tablets are available with 200mcg (0.2mg) of levothyroxine sodium, USP. This medication should be stored in tight, light-resistant containers and kept away from children. The usual dosage should be reviewed in literature that accompanies the medication. It is manufactured by Piiva Hvatska d.oo in Croatia and distributed by Teva Pharmaceuticals in Parsippany. The medication comes in a pack of 90 scored tablets that can be stored between 15° and 30°C. The information on the pack is in accordance with the USP Controlled Room temperature.*

FDA Label Image

Label 300 Mcg, 90 Tablets (Image 13)

Levothyrox is a medication that contains 300 micrograms of levothyroxine sodium, USP per scored tablet. It is dispensed in tight containers and should be kept out of reach of children. The recommended dosage can be found in the accompanying literature. This medication should be stored at a temperature between 15°C to 30°C. It is manufactured in Croatia by Piiva Hvatska d.oo and distributed by Teva Pharmaceuticals. This information is valid as of October 2021.*

FDA Label Image

Label 25 Mcg, 90 Tablets (Image 2)

Each tablet contains 25 mcg of levothyroxine sodium, USP. It comes in light-resistant containers and should be kept out of reach of children. The usual dosage can be found in the accompanying literature. It should be stored at 25°C with permitted excursions to 15° to 30°C, protected from light and moisture. The manufacturer is Pliva Hivatska d.o.o. in Zagreb, Croatia, and the tablets are distributed by Teva Pharmaceuticals in Parsippany, NJ. The product code is 50480-8682-9835.*

FDA Label Image

Label 50 Mcg, 90 Tablets (Image 3)

This is a description of a medication containing 50 mcg of evothyroxine sodium in each scored tablet. The medication should be kept in a tight, light-resistant container and stored at temperatures between 15 to 30°C. The medication's complete prescribing information can be found in accompanying literature. The medication was manufactured in Croatia by Piiva Hvatska doo and made for Teva Pharmaceuticals in Parsippany, New Jersey.*

FDA Label Image

Label 75 Mcg, 90 Tablets (Image 4)

This is a description of Levothyroxine Tablets, USP, which are used for treating hypothyroidism. The tablets contain 75 mcg (0.075 mg) of Levothyroxine sodium, USP and should be dispensed in tight, light-resistant containers. The usual dosage is provided in the accompanying literature. The tablets should be stored at 25°C (77°F), with permitted excursions to 15° to 30°C (59° 10 86°F). The tablets are manufactured by Piva Hvatska d.oo in Zagreb, Croatia, for Teva Pharmaceuticals in Parsippany, New Jersey. The text includes the National Drug Code (NDC), dosage information, and storage instructions.*

FDA Label Image

Label 88 Mcg, 90 Tablets (Image 5)

Levothyrox is a medication available in tablet form, specifically in 88 mcg (0.088 mg) doses. The drug is contained in light-resistant containers to avoid degradation, and its storage should not exceed 15° to 30°C. The manufacturer, Piiva Hvatska d.o, is located in Zagreb, Croatia, and Teva Pharmaceuticals handles the product's distribution. For dosage information, refer to the accompanying literature provided.*

FDA Label Image

Label 100 Mcg, 90 Tablets (Image 6)

This appears to be a description of a medication named "Levothyroxine Tablets, USP" with a strength of 100 mcg (0.1 mg) per scored tablet. It is advised to store the medication in tight, light-resistant containers at a temperature of 25°C (77°F) and away from light and moisture. The medication is manufactured in Croatia by Piiva Hvatska d.oo and is distributed by Teva Pharmaceuticals in Parsippany, NJ. The text also includes a product code, expiration date, and a serialization coding area.*

FDA Label Image

Label 112 Mcg, 90 Tablets (Image 7)

This text describes a medication called Levothyroxine tablets, USP with a strength of 112 mcg. The tablets come in a bottle with an NDC code and should be stored in a light-resistant container at a temperature of 15° to 30°C. The medication is manufactured by Piva Hvatska d.oo. in Croatia and distributed by Teva Pharmaceuticals in Parsippany, NJ. The description advises to refer to accompanying literature for complete prescribing information. There is also an identification code and serialization coding area on the bottle.*

FDA Label Image

Label 125 Mcg, 90 Tablets (Image 8)

This is a medication bottle label for Levothyroxine Sodium Tablets, with a strength of 125 micrograms (0.125mg) per scored tablet. The NDC number is 0480-8707-98. It contains instructions to store the medication in a tight, light-resistant container at room temperature and protect from light and moisture. The medication was manufactured in Croatia by Piiva Hvatska and is distributed by Teva Pharmaceuticals in Parsippany, NJ. The label also includes a serialization coding area. The usual dosage information is provided in accompanying literature.*

FDA Label Image

Label 137 Mcg, 90 Tablets (Image 9)

This is a description of a medication called Levothyroxine, which comes in tablet form. Each scored tablet contains 137mg of Levothyroxine sodium, and it should be dispensed in tightly-sealed, light-resistant containers as defined by the USP. The medication should be kept out of reach of children and stored at 25°C (77°F), with excursions permitted to 15° to 30°C (59° 10 86°F) to protect from light and moisture. The manufacturer, Piiva Hvatska d.oo, is located in Zagreb, Croatia, and the medication is manufactured for Teva Pharmaceuticals in Parsippany, NJ, USA. The available information indicates that this is a prescription medication.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.